Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. (Q43290336)

18 November 2017

Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. (English)

1 reference

18 November 2017

0 references

0 references

1 reference

1 reference

Sandra Laban

2

0 references

Arno R van der Slik

object named as

Arno R van der Slik

4

0 references

author name string

Wendy W J Unger

1

1 reference

18 November 2017

Fleur S Kleijwegt

3

1 reference

18 November 2017

Bart O Roep

5

1 reference

18 November 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

European Journal of Immunology

18 November 2017

1 reference

18 November 2017

39

1 reference

18 November 2017

3147-3159

1 reference

18 November 2017

11

1 reference

Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis.

18 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

Enhanced CD4 T cell responsiveness in the absence of 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

Immunomodulatory Dendritic Cells Inhibit Th1 Responses and Arthritis via Different Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Development, cytokine profile and function of human interleukin 17-producing helper T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Effects of dexamethazone on LPS-induced activationand migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

PD-1 and PD-1 ligands: from discovery to clinical application

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

4-1BB-mediated immunotherapy of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Evolving concepts of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Type 1 T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Fas ligation induces apoptosis of CD40-activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839103

7 January 2021

Identifiers

DOI

10.1002/EJI.200839103

1 reference

18 November 2017

1 reference